Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03355456 · ClinicalTrials.gov registry record · NA
Low Voltage-Directed Catheter Ablation for Atrial Fibrillation
A NA study of Atrial Fibrillation - Symptomatic, sponsored by Ohad Ziv.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 1
- Study location
NCT03355456 is a NA study of Atrial Fibrillation - Symptomatic that is actively recruiting participants, run by Ohad Ziv. The registered enrollment target is 250 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03355456, a NA study of Atrial Fibrillation - Symptomatic, is actively recruiting participants, sponsored by Ohad Ziv.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
A two-pronged approach to evaluate long term success of non-paroxysmal ablation when using a: 1. specified low voltage-directed with pulmonary vein isolation (LD+PVI) approach compared to , 2. an approach of pulmonary vein isolation (PVI) alone.
Conditions Studied
Interventions
- PROCEDURE Radiofrequency ablation
Study Locations (1)
Ohio
- MetroHealth Medical Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2019-07-14 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03355456
The ClinicalTrials.gov registry entry for NCT03355456 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohad Ziv, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Atrial Fibrillation - Symptomatic appearing as the primary indexed condition, and to 1 intervention - of which Radiofrequency ablation is the first listed.
NCT03355456 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT03355456 about?
NCT03355456 is a clinical study titled "Low Voltage-Directed Catheter Ablation for Atrial Fibrillation". A two-pronged approach to evaluate long term success of non-paroxysmal ablation when using a: 1. specified low voltage-directed with pulmonary vein isolation (LD+PVI) approach compared to , 2. an approach of pulmonary vein isolation (PVI) alone.
What is the current status of trial NCT03355456?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2019-07-14. Estimated completion is 2027-12-31.
What conditions does trial NCT03355456 study?
This clinical trial studies the following conditions: Atrial Fibrillation - Symptomatic.
What interventions are being tested in trial NCT03355456?
The interventions under investigation include: Radiofrequency ablation (PROCEDURE).
Who is sponsoring clinical trial NCT03355456?
This trial is sponsored by Ohad Ziv, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03355456 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.